Horne Amelia Dale, Clifford Julianne, Goldenthal Karen L, Kleppinger Cynthia, Lachenbruch Peter A
Division of Biostatistics, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research (CBER), FDA, HFM-217, 1401 Rockville Pike, Rockville, MD 20852-1448, USA.
Vaccine. 2004 Nov 15;23(1):84-90. doi: 10.1016/j.vaccine.2004.04.037.
This paper discusses the US Food and Drug Administration's approach to evaluation of vaccines in general, and vaccines against diseases of bioterrorism in particular. We summarize the scientific bases for development and approval of vaccines and then discuss specific issues regarding vaccines against disease organisms that could potentially be used as weapons of bioterrorism.
本文讨论了美国食品药品监督管理局评估疫苗的一般方法,特别是针对生物恐怖主义疾病的疫苗。我们总结了疫苗研发和批准的科学依据,然后讨论了针对可能被用作生物恐怖主义武器的致病生物体的疫苗的具体问题。